DC Circ. Ruling Heightens HHS Contract Pharmacy Challenges

By Ross Margulies, Andrew London and Patrick Brennan (June 4, 2024, 2:09 PM EDT) -- On May 21, the U.S. Court of Appeals for the District of Columbia Circuit issued its decision in the consolidated cases of United Therapeutics Corporation v. Carole Johnson and Novartis Pharmaceuticals v. Carole Johnson, holding that the Section 340B drug pricing program does not prohibit drug manufacturers from imposing contract pharmacy restrictions....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!